title: Rethinking cellular targets for lead neurotoxicity.
authors.forename: R D
authors.initials: RD
authors.lastname: Poretz
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D002553:Cerebroside-Sulfatase / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D020022:Genetic Predisposition to Disease; D006801:Humans; D020264:Lead Poisoning, Nervous System, Childhood / Q000201:enzymology* / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000523:psychology; D007858:Learning; D058953:Neural Stem Cells / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D055495:Neurogenesis / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D009836:Oligodendroglia / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D015398:Signal Transduction
chemical_list: D002553:Cerebroside-Sulfatase